While women make up 70 percent of cases of Alzheimer’s disease and 65 percent of cases of depression, only about half of one percent of brain-imaging research is related to women. This disparity continues even in drug approvals, such as lecanemabirmb, which U.S. Food and Drug Administration recently approved for the treatment of early Alzheimer’s disease, but it may not slow the disease in women.

Big oof!!!

“It’s high time to make the brain a major focus of women’s health,” says Sacher.

Or even better make women’s health the focus of medical research as it has been ignored for decades. Just like research has been on mostly white people.